Lai Wei

6PUBLICATIONS
6CO-AUTHORS
Cancer geneticsNutrigenomics and personalised nutritionGene and molecular therapyMajor global burdens of diseaseOther education not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 13, 2026
Hypertension Associated with the Risk of Extrahepatic Cancers in the Metabolic Dysfunction-associated Steatotic Liver Disease Population: A Multicenter Cross-sectional Study in China.

Xinyue Zhao, Feng Xue, Shanshan Wang

|Nov 15, 2024
Guideline for the Prevention and Treatment of Metabolic Dysfunction-associated Fatty Liver Disease (Version 2024).

Jian-Gao Fan, Xiao-Yuan Xu, Rui-Xu Yang

|Aug 12, 2024
THR-β Agonist for Nonalcoholic Steatohepatitis Treatment: Challenges of a Promising Drug.

Feng Xue, Lai Wei

|Apr 04, 2022
Impact of NAFLD on the outcome of patients with chronic hepatitis B in Asia.

Ming Yang, Lai Wei

|Feb 12, 2020
Reply.

Lai Wei, Pik Eu Jason Chang, Quentin M Anstee

|Oct 11, 2019
qFIBS: An Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis.

Feng Liu, George Boon-Bee Goh, Dina Tiniakos

Pageof 1

Frequent Collaborators

2 joint publications

Quentin M Anstee

2 joint publications

Pik-Eu Jason Chang

1 joint publications

Jing-Min Zhao

1 joint publications

Ming Yang